SaTScan detects an acute HCV outbreak cluster in California, showing the potential of automated surveillance, though real-time testing is needed.
Publication|Articles|July 27, 2026
- August 2026
- Volume 32
- Issue Spec 9
The Promise and Politics of Creating mRNA Vaccines in Cancer
Author(s)Ryan Flinn
Our August cover story from Evidence-Based Oncology.
Advertisement
Advertisement
In June, Moderna and Merck reported clinical trial follow-up results showing that their combination mRNA cancer vaccine and immunotherapy reduced the risk of melanoma recurrence in high-risk patients by nearly half over 5 years.1
Related to this article
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Cleveland roundtable panelists across 4 disease states name access, not evidence, as the shared barrier to care.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Advertisement
Advertisement